<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="59186">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02335489</url>
  </required_header>
  <id_info>
    <org_study_id>14-SMI-2013</org_study_id>
    <nct_id>NCT02335489</nct_id>
  </id_info>
  <brief_title>A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Neuropathic Pain of the Foot and/or Lower Leg</brief_title>
  <official_title>A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Neuropathic Pain of the Foot and/or Lower Leg</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      14-SMI-2013 is a post market, observational, questionnaire based study to assess the
      effectiveness of the commercially available Axium neurostimulator in the management of
      neuropathic pain of the foot and/or lower limb
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    A significant local issue has to led to the suspension of recruitment, this study will be
    terminated in the coming months
  </why_stopped>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Relief - Assessed by Change in Pain Intensity from Pre-Treatment baseline</measure>
    <time_frame>Post implantation at; 1 week and 1, 3, 6 and12 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">10</enrollment>
  <condition>Chronic Neuropathic Pain</condition>
  <arm_group>
    <arm_group_label>Treated Subjects</arm_group_label>
    <description>All subjects recruited and treated with the Axium neurostimulator</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantation with the commercially available Axium neurostimulator</intervention_name>
    <arm_group_label>Treated Subjects</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Chronic Neuropathic Pain of the Foot and/or Lower Leg
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is at least 18 years old

          2. Subject is able and willing to comply with the follow-up schedule and protocol

          3. Chronic, intractable pain in the foot and/or lower leg for at least 6 months

          4. Failed conservative treatments for chronic pain including but not limited to
             pharmacological therapy, physical therapy and interventional pain procedures for
             chronic pain

          5. Minimum baseline pain rating of 60 mm on the Visual Analog Scale in the primary
             region of pain

          6. Subject is able to provide written informed consent

        Exclusion Criteria:

          1. Female subject of childbearing potential is pregnant/nursing, plans to become
             pregnant or is unwilling to use approved birth control

          2. Escalating or changing pain condition within the past month as evidenced by
             investigator examination

          3. Subject has had corticosteroid therapy at an intended site of stimulation within the
             past 30 days

          4. Subject has had radiofrequency treatment of an intended target Dorsal Root Ganglion
             within the past 3 months

          5. Subject currently has an active implantable device including implantable cardioverter
             defibrillator, pacemaker, spinal cord stimulator or intrathecal drug pump

          6. Subject is unable to operate the device

          7. Subjects with indwelling devices that may pose an increased risk of infection

          8. Subjects currently has an active infection

          9. Subject has participated in another clinical investigation within 30 days

         10. Subject has a coagulation disorder or uses anticoagulants that, in the opinion of the
             investigator, precludes participation

         11. Subject has been diagnosed with cancer in the past 2 years.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>AZ Nikolaas</name>
      <address>
        <city>Sint-Niklaas</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 25, 2016</lastchanged_date>
  <firstreceived_date>January 7, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
